Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
11 drugs in development
By Therapeutic Area
top 6
R&D Momentum
98/100
Pipeline Velocity
85/100
Trial Completion Rate
75/100
Pipeline Concentration
24/100
Pipeline Freshness
74/100
Strategic Signals
Activity
Last 14 days
Pilot Study of INCB081776 Together With Palliative Radiation and Anti-PD-1 Checkpoint Blockade With Pembrolizumab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
Transforming Risk Factors in a High Stroke Risk Native American Population Through a Cultural Nutritional Program
Enovis High Ankle Sprain Brace Testing
Clinical Interventions to Acutely Enhance Quadriceps Output After Anterior Cruciate Ligament Reconstruction
The Advancing Dynamic And Personalized Training Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)